Minghui Pharmaceutical Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • IPO Registration

  • Employees
  • 127

Employees

  • Latest Deal Type
  • IPO
  • (Postponed)

  • Financing Rounds
  • 6

Minghui Pharmaceutical General Information

Description

Developer of clinical-stage oncology and autoimmune therapeutics designed for solid tumors and immune-mediated diseases. The company provides proprietary antibody-drug conjugates (ADCs), bispecific antibodies, and targeted inhibitors, enabling patients with advanced cancers and autoimmune conditions with innovative and potentially safer treatment options.

Contact Information

Ownership Status
In IPO Registration
Financing Status
Private Equity-Backed
Corporate Office
  • Room 1002, 10/F, Building 1
  • No. 333 Shengrong Road, China (Shanghai) Pilot Free Trade Zone, PRC
  • Shanghai, 201203
  • China
+86 021
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • Room 1002, 10/F, Building 1
  • No. 333 Shengrong Road, China (Shanghai) Pilot Free Trade Zone, PRC
  • Shanghai, 201203
  • China
+86 021

Minghui Pharmaceutical Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Minghui Pharmaceutical Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Minghui Pharmaceutical‘s full profile, request access.

Request a free trial

Minghui Pharmaceutical Patents

Minghui Pharmaceutical Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026171078-A1 Anti-c-met antibody-drug conjugate and use thereof Pending 12-Feb-2025
WO-2026171088-A1 Anti-cdcp1 antibody-drug conjugate and use thereof Pending 12-Feb-2025
WO-2026153364-A1 Preparation method for jak inhibitor compound, and crystal form and intermediate of jak inhibitor compound Pending 14-Jan-2025
WO-2025241867-A1 Anti-b7-h4 antibody-drug conjugate and application thereof Pending 24-May-2024
WO-2025241869-A1 Anti-psma antibody-drug conjugate and use thereof Pending 24-May-2024
To view Minghui Pharmaceutical’s complete patent history, request access »

Minghui Pharmaceutical Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Minghui Pharmaceutical Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Minghui Pharmaceutical‘s full profile, request access.

Request a free trial

Minghui Pharmaceutical FAQs

  • When was Minghui Pharmaceutical founded?

    Minghui Pharmaceutical was founded in 2018.

  • Where is Minghui Pharmaceutical headquartered?

    Minghui Pharmaceutical is headquartered in Shanghai, China.

  • What is the size of Minghui Pharmaceutical?

    Minghui Pharmaceutical has 127 total employees.

  • What industry is Minghui Pharmaceutical in?

    Minghui Pharmaceutical’s primary industry is Drug Discovery.

  • Is Minghui Pharmaceutical a private or public company?

    Minghui Pharmaceutical is a Private company.

  • What is Minghui Pharmaceutical’s current revenue?

    The current revenue for Minghui Pharmaceutical is .

  • How much funding has Minghui Pharmaceutical raised over time?

    Minghui Pharmaceutical has raised $289M.

  • Who are Minghui Pharmaceutical’s investors?

    5Y Capital, BioTrack Capital, Boyuan Capital, OrbiMed, and Qiming Venture Partners are 5 of 12 investors who have invested in Minghui Pharmaceutical.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process